Morgan Stanley GHC Event | HZNP Message Board Posts

Horizon Pharma, Inc.

  HZNP website

HZNP   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  1693 of 1842  at  9/12/2019 5:39:16 PM  by

geringerart


 In response to msg 1690 by  Drummer1517
view thread

Re: Morgan Stanley GHC Event

Although I'm not a big fan of anecdotal evidence (e.g. A for FA reports), off label use of Methotrexate with K showed 100% results. What is not appreciated by the market (at all) is that K is all about the number of vials per patient. Even for those who go on K, many do not finish treatment and I believe the average is something like 6 vials used. There is still plenty of benefit to those who get the treatment but can't complete it, so that is not an issue, but increased vials means many more $$$$ (not figured currently into the equation). There is also the possibility that use of immuno modulator could allow for retreatment (something that is now at Zero), should tofu should CRG recur in patients.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 180
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...